← Evidence map

ArticleClinics (Sao Paulo, Brazil)2019

Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?

Fabio Vieira Teixeira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2019
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31576920